Stem Cells To Skin Rejuvenation (ISCO)

April 21, 2009 · Filed Under General 

International Stem Cell Corporation (OTCBB: ISCO) announced that it has received “excellent preliminary results” for a new retail skin rejuvenation product.  It also noted that this was developed as a result of its fundamental research into Parthenogenic Stem Cells of a proprietary combination of the special growth media for human skin tissue created by the company.  The product coupled with the by-products of the production of Parthenogenic Stem Cells, appears to have a dramatic impact on the restoration and retention of skin moisture.

The company is also claiming that the product may have longer term benefits for skin rejuvenation.  Further testing is to be conducted to confirm this preliminary data. If subsequent research supports the promising initial results, the Company plans to launch a new line of skin rejuvenation products based on this discovery.

The company called this as showing the early signs of being a significant breakthrough in providing an oil free skin moisturizing product, and one that might also provide long term benefits in reducing wrinkles and other visible signs of the natural aging process.

This is an OTC Bulltin Board stock, so as always keep in mind that filing requirements can be different and trade data may be delayed.  It is also in penny stock land.

Jon C. Ogg

Tags: ,

Comments

Comments are closed.

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed